+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cell Surface Markers Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 195 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5650789

Market growth fueled by increasing adoption of sophisticated analytical technologies and in-vitro diagnostic tools

The Global Cell Surface Markers Market is estimated to be USD 712.92 Mn in 2022 and is expected to reach USD 1104.48 Mn by 2027, growing at a CAGR of 9.15%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Cell Surface Markers Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Cell Surface Markers Market is segmented based on Product, Source, Cell Type, Application, End User, and Geography.
  • By Product, the market is classified into Antibodies and PCR Arrays.
  • By Source, the market is classified into Mice and Rats.
  • By Cell Type, the market is classified into B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers and T Cell Surface Markers.
  • By Application, the market is classified into Clinical and Research.
  • By End User, the market is classified into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories and Pharmaceutical & Biotechnology Companies.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Abcam, PLC, Agilent Technologies, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Bio-Techne Corp., BioLegend, Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Cell Surface Markers Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Cell Surface Markers Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cell Surface Markers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Demand for Precision Medicine
4.1.2 Growing Healthcare and Research Expenditure
4.2 Restraints
4.2.1 Time-intensive Antibody Development Process
4.3 Opportunities
4.3.1 Growing Investment in Research and Development to Launch New Drugs
4.3.2 The Emergence of New Therapies to Target Liver Cancer Stem Cells
4.4 Challenges
4.4.1 Complex Products and Expensive Instruments and Reagents Used in Cell Marker
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Cell Surface Markers Market, By Product
6.1 Introduction
6.2 Antibodies
6.3 PCR Arrays
7 Global Cell Surface Markers Market, By Source
7.1 Introduction
7.2 Mice
7.3 Rats
8 Global Cell Surface Markers Market, By Cell Type
8.1 Introduction
8.2 B Cell Surface Markers
8.3 Monocyte Cell Surface Markers
8.4 NK Cell Surface Markers
8.5 T Cell Surface Markers
9 Global Cell Surface Markers Market, By Application
9.1 Introduction
9.2 Clinical
9.2.1 Immunodeficiency Diseases
9.2.2 Oncology
9.3 Research
9.3.1 Drug Discovery
9.3.2 Immunology
9.3.3 Stem Cell Research
10 Global Cell Surface Markers Market, By End User
10.1 Introduction
10.2 Academic & Research Institutes
10.3 Hospitals & Clinical Testing Laboratories
10.4 Pharmaceutical & Biotechnology Companies
11 Americas’ Cell Surface Markers Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Cell Surface Markers Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Cell Surface Markers Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Cell Surface Markers Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Abbott Laboratories
16.2 Abcam, PLC
16.3 Agilent Technologies, Inc.
16.4 Becton, Dickinson and Company
16.5 Beckman Coulter, Inc.
16.6 Bio-Rad Laboratories
16.7 Bio-Techne Corp.
16.8 BioLegend, Inc.
16.9 Cell Signaling Technology, Inc.
16.10 Danaher Corp.
16.11 Diasorin SpA
16.12 F. Hoffman-La Roche Ag
16.13 GenScript Biotech Corp.
16.14 Merk KGaA
16.15 Nihon Kohden Corp.
16.16 Nexcelom Bioscience, LLC
16.17 Qiagen NV
16.18 Sysmex Corp.
16.19 Thermo Fisher Scientific, Inc.
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Abcam, PLC
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne Corp.
  • BioLegend, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corp.
  • Diasorin SpA
  • F. Hoffman-La Roche AG
  • GenScript Biotech Corp.
  • Merk KGaA
  • Nihon Kohden Corp.
  • Nexcelom Bioscience, LLC
  • Qiagen NV
  • Sysmex Corp.
  • Thermo Fisher Scientific, Inc.